The Global Fund and partners began rolling out PlusLife MiniDock Ultra systems across 13 countries with $50 million in coordinated funding drawn from the Children’s Investment Fund Foundation. The initiative is designed to expand access to near point-of-care TB testing infrastructure using the MiniDock Ultra platform. The rollout is framed as an infrastructure and diagnostic deployment effort, rather than a single-country study, with the system integration expected to support faster testing workflows and improved diagnostic coverage where centralized lab capacity can be limited. The funding commitment and multi-country deployment underline growing emphasis on scaling point-of-care diagnostics in TB programs, where turnaround time and geographic coverage can directly influence detection and treatment initiation.